Prophylactic use of gabapentin for prevention of succinylcholine-induced fasciculation and myalgia: A randomized, double-blinded, placebo-controlled study

Journal of Postgraduate Medicine

Volumn 58, Issue 1, 2012, Pages 19-22

  Pandey, Chandra Kant ^a   Tripathi, M ^b   Joshi, G ^b   Karna, S T ^b   Singh, N ^b   Singh, P K ^b  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fasciculation; gabapentin; succinylcholine induced myalgia

Indexed keywords

FENTANYL; GABAPENTIN; OXYGEN; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ADULT; ANESTHESIA; ANESTHESIA INDUCTION; ARTICLE; CHOLECYSTECTOMY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FASCICULATION; FEMALE; HUMAN; INTUBATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NEUROMUSCULAR BLOCKING; POSTOPERATIVE PAIN; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TERTIARY HEALTH CARE;

ADULT; AGED; AMINES; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; CHOLECYSTECTOMY, LAPAROSCOPIC; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FASCICULATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR DISEASES; PAIN, POSTOPERATIVE; SEVERITY OF ILLNESS INDEX; SUCCINYLCHOLINE; TREATMENT OUTCOME;

EID: 84859175473     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.93248     Document Type: Article

References (33)

1. Stacey MR, Barclay K, Asai T, Vaughan RS. Effects of magnesium sulphate on suxamethonium-induced complications during rapidsequence induction of anaesthesia. Anaesthesia 1995;50:933-6.
2. Smith I, Ding Y, White PF. Muscle pain after outpatient laparoscopyinfluence of propofol versus thiopentone and enflurane. AnesthAnalg 1993;76:1181-4.
3. Kararmaz A, Kaya S, Turhanoglu S, Ozyilmaz MA. Effects of high-dose propofol on succinylcholine-induced fasciculations and myalgia. ActaAnaesthesiolScand 2003;47:180-4.
4. Oxorn DC, Whatley GS, Knox JW, Hooper J. The importance of activity and pretreatment in the prevention of suxamethonium myalgias. Br J Anaesth 1992;69:200-1.
5. Harvey SC, Roland P, Bailey MK, Tomlin MK, Williams A. A randomized, double-blind comparison of rocuronium, d-Tubocurarine, and "mini dose" succinylcholine for preventing succinylcholine-induced muscle fasciculations. AnesthAnalg 1998;87:719-22.
6. Laurence AS. Myalgia and biochemical changes following intermittent suxamethonium administration. Effects of alcuronium, lignocaine, Midazolam and suxamethonium pre-Treatment's on serum myoglobin, creatinine kinase and myalgia. Anaesthesia 1987;42:503-10.
7. Mingus ML, Herlich A, Eisenkraft JB. Attenuation of suxamethonium myalgias. Effect of midazolam and vecuronium. Anaesthesia 1990;45:834-7.
8. Hatta V, Saxena A, Kaul HL. Phenytoin reduces suxamethoniuminduced myalgia. Anaesthesia 1992;47:664-7.
9. Leeson-Payne CG, Nicoll JM, Hobbs GJ. Use of ketorolac in the prevention of suxamethonium myalgia. Br J Anaesth 1994;73:788-90.
10. Mencke T, Schreiber JU, Becker C, Bolte M, Fuchs-Buder T. Pretreatment before succinylcholine for outpatient anesthesia? Anesth Analg 2002;94:573-6.
11. Yun MJ, Kim YH, Go YK, Shin JE, Ryu CG, Kim W, et al. Remifentanil attenuates muscle fasciculations by succinylcholine. Yonsei Med J 2010;51:585-9.
12. Nimmo SM, McCann N, Broome IJ, Robb HM. Effectiveness and sequelae of very low dose Suxamethonium for nasal intubation. Br J Anaesth 1995;74:31-4.
13. Pandey CK, Singhal V, Kumar M, Lakra A, Ranjan R, Pal R, et al. Gabapentin provides effective postoperative analgesia whether administered pre-emptively or post-incision. Can J Anesth 2005;52:827-31.
14. Pandey CK, Patra P, Pant KC, Singh PK. Gabapentin for the treatment of refractory dysesthetic pain after open cholecystectomy. Anesth. Analg. 2006;103:263.
15. Pandey CK, Singh N, Singh PK. Gabapentin for refractory idiopathic trigeminal neuralgia. J Indian Med Assoc 2008;106:124-5.
16. Pühringer FK, Khuenl-Brady KS, Koller J, Mitterschiffthaler G. Evaluation of the endotracheal intubating conditions of rocuronium (ORG 9426) and succinylcholine in outpatient surgery. Anesth Analg 1992;75:37-40.
17. Newnam PT, Loudon JM. Muscle pain following administration of suxamethonium: The aetiological role of muscular fitness. Br J Anaesth 1966;38:533-40.
18. McLoughlin C, Elliott P, McCarthy G, Mirakhur RK. Muscle pains and biochemical changes following suxamethonium administration after six pretreatment regimens. Anaesthesia 1992;47:202-6.
19. Suarez-Kurtz G, Eastwood AB. Release of sarcoplasmic enzymes from frog skeletal muscle. Am J Physiol 1981;241:C98-105.
20. McLoughlin C, Nesbitt GA, Howe JP. Suxamethonium induced myalgia and the effect of preoperative administration of oral aspirin. Anaesthesia 1988;43:565-7.
21. McLoughlin C, Leslie K, Caldwell JE. Influence of dose on suxamethonium induced muscle damage. Br J Anaesth 1994; 73:194-8.
22. Collier CB. Suxamethonium and early electrolyte changes. Anaesthesia 1978;33:454-61.
23. Jackson MJ, Jones DA, Edwards RH. Experimental skeletal muscle damage: The nature of calcium activated degenerative processes. Eur J Clin Invest 1984;14:369-74.
24. Hartman GS, Fiamengo SA, Riker WF Jr. Mechanism of fasciculations and their prevention by d-Tubocurarine or diphenylhydantoin. Anesthesiology 1986;65:405-13.
25. Maddineni VR, Mirakhur RK, Cooper AR. Myalgia and biochemical changes following suxamethonium after induction of anaesthesia with thiopentone or propofol. Anaesthesia 1993;48:626-8.
26. Schreiber JU, Lysakowski C, Fuchs-Buder T, Tramèr MR. Prevention of succinylcholine-induced fasciculation and myalgia: A meta-Analysis of randomized trials. Anesthesiology 2005;103:877-84.
27. Fatemeh H, Mojgan R. Comparison of atracurium and "mini-dose" succinylcholine for preventing succinylcholine-induced muscle fasciculations: A randomized, double-blind, placebo-controlled study. ActaAnaesthesiol Taiwan 2010;48:28-32.
28. Rahimi M, Makarem J, Goharrizi AG. Succinylcholine-induced myalgia in obstetric patients scheduled for caesarean section-diclofenacvs placebo patches.Middle East J Anesthesiol 2009;20:417-22.
29. Tracey DJ, De Biasi S, Phend K, Rustioni A. Aspartate like immunoreactivity in primary afferent neurons. Neuroscience 1991;40:673-86.
30. Field MJ, Hughes J, Singh L. Further evidence for the role of the alpha (2) delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000;131:282-6.
31. Fink K, Meder W, Dooley DJ, Göthert M. Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 2000;130:900-6.
32. Hutson SM, Berkich D, Drown P, Xu B, Aschner M, LaNoue KF. Role of branched chain aminotransferase coenzymes and gabapentin in neurotransmitter metabolism. J Neurochem 1998;71:863-74.
33. Rasmussen KG, Petersen KN, Sticka JL, Wieme LJ, Zosel JH, Marienau ME, et al. Correlates of myalgia in electroconvulsive therapy.J ECT 2008;24:84-7